Early research (Phase 1)Study completedNCT02568306
What this trial is testing
A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects
Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 93